US Stock MarketDetailed Quotes

TMO Thermo Fisher Scientific

Watchlist
  • 528.870
  • -5.550-1.04%
Close Dec 4 16:00 ET
  • 528.870
  • 0.0000.00%
Post 20:01 ET
202.29BMarket Cap33.16P/E (TTM)

Thermo Fisher Scientific Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 29, 2024
(Q1)Mar 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jul 1, 2023
(Q1)Apr 1, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.40%2.16B
27.47%1.96B
71.47%1.25B
-8.17%8.41B
6.77%3.72B
24.63%2.41B
0.79%1.54B
-66.89%729M
-1.70%9.15B
41.92%3.49B
Net income from continuing operations
-3.89%1.63B
14.10%1.55B
3.02%1.33B
-14.44%5.96B
2.03%1.61B
13.15%1.7B
-18.35%1.36B
-41.80%1.29B
-9.94%6.96B
-5.12%1.57B
Operating gains losses
----
----
----
----
----
----
----
----
-96.61%26M
--0
Depreciation and amortization
-13.36%739M
-7.49%791M
-2.68%836M
0.74%3.41B
-1.06%839M
1.79%853M
2.27%855M
0.00%859M
30.44%3.38B
24.16%848M
Deferred tax
-32.01%-400M
-94.51%-354M
-73.29%-253M
-30.65%-1.3B
-403.01%-669M
-16.09%-303M
30.53%-182M
56.93%-146M
-53.79%-995M
30.73%-133M
Other non cash items
-9.91%100M
-32.21%101M
-70.17%54M
16.36%562M
202.50%121M
-26.97%111M
156.90%149M
-22.32%181M
209.62%483M
211.11%40M
Change In working capital
433.33%30M
69.92%-216M
48.66%-787M
50.89%-495M
62.97%1.77B
97.55%-9M
15.43%-718M
-75.20%-1.53B
33.42%-1.01B
456.25%1.08B
-Change in receivables
----
----
----
126.66%209M
----
----
----
----
-4,711.76%-784M
----
-Change in inventory
----
----
----
172.48%598M
----
----
----
----
22.54%-825M
----
-Change in payables and accrued expense
----
----
----
-177.16%-500M
----
----
----
----
35.28%648M
----
-Change in other working capital
----
----
----
-1,606.38%-802M
----
----
----
----
95.03%-47M
----
Cash from discontinued investing activities
Operating cash flow
-10.27%2.17B
27.27%1.96B
71.60%1.25B
-8.17%8.41B
6.77%3.72B
24.63%2.41B
0.79%1.54B
-66.89%729M
-1.70%9.15B
41.92%3.49B
Investing cash flow
Cash flow from continuing investing activities
-202.88%-3.58B
42.89%-253M
35.39%-2.03B
-138.17%-5.14B
28.38%-376M
-116.70%-1.18B
-5.73%-443M
-368.96%-3.14B
90.16%-2.16B
97.19%-525M
Net PPE purchase and sale
5.26%-252M
-1.79%-285M
24.12%-343M
37.27%-1.39B
27.57%-394M
51.01%-266M
43.32%-280M
29.15%-452M
11.35%-2.22B
33.66%-544M
Net business purchase and sale
-244.55%-3.13B
--0
--0
-9,284.62%-3.66B
--0
-91,000.00%-909M
---47M
-6,660.00%-2.7B
99.80%-39M
--0
Net investment purchase and sale
-1,672.73%-195M
117.65%27M
---1.69B
366.67%70M
--234M
---11M
---153M
--0
87.50%15M
----
Net other investing changes
-80.00%1M
-86.49%5M
-50.00%7M
-290.48%-160M
-5,500.00%-216M
266.67%5M
-50.67%37M
75.00%14M
300.00%84M
200.00%4M
Cash from discontinued investing activities
Investing cash flow
-202.96%-3.58B
42.89%-253M
35.39%-2.03B
-138.17%-5.14B
28.38%-376M
-116.70%-1.18B
-5.73%-443M
-368.96%-3.14B
90.16%-2.16B
97.19%-525M
Financing cash flow
Cash flow from continuing financing activities
-164.15%-1.19B
92.10%-115M
29.81%-1.82B
-28.90%-3.62B
-159.72%-1.43B
1,328.48%1.86B
23.57%-1.46B
17.55%-2.59B
-142.70%-2.81B
-71.76%2.39B
Net issuance payments of debt
-156.14%-1.11B
99.92%-1M
139.09%1.21B
-123.70%-155M
-137.44%-1.31B
197,300.00%1.97B
27.40%-1.33B
150.00%504M
-92.66%654M
-59.40%3.49B
Net common stock issuance
--0
--0
0.00%-3B
0.00%-3B
--0
--0
--0
-50.00%-3B
-50.00%-3B
---1B
Cash dividends paid
-11.11%-150M
-10.37%-149M
-15.38%-135M
-14.95%-523M
-16.24%-136M
-14.41%-135M
-15.38%-135M
-13.59%-117M
-15.19%-455M
-13.59%-117M
Net other financing activities
272.22%67M
775.00%35M
445.00%109M
722.22%56M
-30.00%14M
156.25%18M
-89.19%4M
158.82%20M
-113.85%-9M
-74.68%20M
Cash from discontinued financing activities
Financing cash flow
-164.15%-1.19B
92.10%-115M
29.77%-1.82B
-28.90%-3.62B
-159.72%-1.43B
1,328.48%1.86B
23.57%-1.46B
17.55%-2.59B
-142.70%-2.81B
-71.76%2.39B
Net cash flow
Beginning cash position
125.09%7.1B
57.69%5.52B
-5.15%8.1B
90.09%8.54B
110.22%6.17B
65.51%3.15B
25.94%3.5B
90.09%8.54B
-56.55%4.49B
-75.65%2.93B
Current changes in cash
-184.26%-2.6B
543.73%1.59B
48.06%-2.6B
-108.55%-358M
-64.15%1.92B
148.83%3.09B
54.90%-359M
-210.35%-5.01B
169.30%4.19B
168.91%5.35B
Effect of exchange rate changes
339.73%175M
-225.00%-15M
170.97%22M
41.01%-82M
-96.00%10M
65.57%-73M
115.38%12M
68.69%-31M
-171.65%-139M
18.48%250M
End cash Position
-24.29%4.67B
125.09%7.1B
57.69%5.52B
-5.15%8.1B
-5.15%8.1B
110.22%6.17B
65.51%3.15B
25.94%3.5B
90.09%8.54B
90.09%8.54B
Free cash flow
-9.03%1.89B
32.09%1.66B
233.58%904M
0.23%6.93B
12.97%3.32B
49.78%2.08B
22.90%1.26B
-82.65%271M
1.80%6.91B
80.63%2.94B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 29, 2024(Q1)Mar 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jul 1, 2023(Q1)Apr 1, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.40%2.16B27.47%1.96B71.47%1.25B-8.17%8.41B6.77%3.72B24.63%2.41B0.79%1.54B-66.89%729M-1.70%9.15B41.92%3.49B
Net income from continuing operations -3.89%1.63B14.10%1.55B3.02%1.33B-14.44%5.96B2.03%1.61B13.15%1.7B-18.35%1.36B-41.80%1.29B-9.94%6.96B-5.12%1.57B
Operating gains losses ---------------------------------96.61%26M--0
Depreciation and amortization -13.36%739M-7.49%791M-2.68%836M0.74%3.41B-1.06%839M1.79%853M2.27%855M0.00%859M30.44%3.38B24.16%848M
Deferred tax -32.01%-400M-94.51%-354M-73.29%-253M-30.65%-1.3B-403.01%-669M-16.09%-303M30.53%-182M56.93%-146M-53.79%-995M30.73%-133M
Other non cash items -9.91%100M-32.21%101M-70.17%54M16.36%562M202.50%121M-26.97%111M156.90%149M-22.32%181M209.62%483M211.11%40M
Change In working capital 433.33%30M69.92%-216M48.66%-787M50.89%-495M62.97%1.77B97.55%-9M15.43%-718M-75.20%-1.53B33.42%-1.01B456.25%1.08B
-Change in receivables ------------126.66%209M-----------------4,711.76%-784M----
-Change in inventory ------------172.48%598M----------------22.54%-825M----
-Change in payables and accrued expense -------------177.16%-500M----------------35.28%648M----
-Change in other working capital -------------1,606.38%-802M----------------95.03%-47M----
Cash from discontinued investing activities
Operating cash flow -10.27%2.17B27.27%1.96B71.60%1.25B-8.17%8.41B6.77%3.72B24.63%2.41B0.79%1.54B-66.89%729M-1.70%9.15B41.92%3.49B
Investing cash flow
Cash flow from continuing investing activities -202.88%-3.58B42.89%-253M35.39%-2.03B-138.17%-5.14B28.38%-376M-116.70%-1.18B-5.73%-443M-368.96%-3.14B90.16%-2.16B97.19%-525M
Net PPE purchase and sale 5.26%-252M-1.79%-285M24.12%-343M37.27%-1.39B27.57%-394M51.01%-266M43.32%-280M29.15%-452M11.35%-2.22B33.66%-544M
Net business purchase and sale -244.55%-3.13B--0--0-9,284.62%-3.66B--0-91,000.00%-909M---47M-6,660.00%-2.7B99.80%-39M--0
Net investment purchase and sale -1,672.73%-195M117.65%27M---1.69B366.67%70M--234M---11M---153M--087.50%15M----
Net other investing changes -80.00%1M-86.49%5M-50.00%7M-290.48%-160M-5,500.00%-216M266.67%5M-50.67%37M75.00%14M300.00%84M200.00%4M
Cash from discontinued investing activities
Investing cash flow -202.96%-3.58B42.89%-253M35.39%-2.03B-138.17%-5.14B28.38%-376M-116.70%-1.18B-5.73%-443M-368.96%-3.14B90.16%-2.16B97.19%-525M
Financing cash flow
Cash flow from continuing financing activities -164.15%-1.19B92.10%-115M29.81%-1.82B-28.90%-3.62B-159.72%-1.43B1,328.48%1.86B23.57%-1.46B17.55%-2.59B-142.70%-2.81B-71.76%2.39B
Net issuance payments of debt -156.14%-1.11B99.92%-1M139.09%1.21B-123.70%-155M-137.44%-1.31B197,300.00%1.97B27.40%-1.33B150.00%504M-92.66%654M-59.40%3.49B
Net common stock issuance --0--00.00%-3B0.00%-3B--0--0--0-50.00%-3B-50.00%-3B---1B
Cash dividends paid -11.11%-150M-10.37%-149M-15.38%-135M-14.95%-523M-16.24%-136M-14.41%-135M-15.38%-135M-13.59%-117M-15.19%-455M-13.59%-117M
Net other financing activities 272.22%67M775.00%35M445.00%109M722.22%56M-30.00%14M156.25%18M-89.19%4M158.82%20M-113.85%-9M-74.68%20M
Cash from discontinued financing activities
Financing cash flow -164.15%-1.19B92.10%-115M29.77%-1.82B-28.90%-3.62B-159.72%-1.43B1,328.48%1.86B23.57%-1.46B17.55%-2.59B-142.70%-2.81B-71.76%2.39B
Net cash flow
Beginning cash position 125.09%7.1B57.69%5.52B-5.15%8.1B90.09%8.54B110.22%6.17B65.51%3.15B25.94%3.5B90.09%8.54B-56.55%4.49B-75.65%2.93B
Current changes in cash -184.26%-2.6B543.73%1.59B48.06%-2.6B-108.55%-358M-64.15%1.92B148.83%3.09B54.90%-359M-210.35%-5.01B169.30%4.19B168.91%5.35B
Effect of exchange rate changes 339.73%175M-225.00%-15M170.97%22M41.01%-82M-96.00%10M65.57%-73M115.38%12M68.69%-31M-171.65%-139M18.48%250M
End cash Position -24.29%4.67B125.09%7.1B57.69%5.52B-5.15%8.1B-5.15%8.1B110.22%6.17B65.51%3.15B25.94%3.5B90.09%8.54B90.09%8.54B
Free cash flow -9.03%1.89B32.09%1.66B233.58%904M0.23%6.93B12.97%3.32B49.78%2.08B22.90%1.26B-82.65%271M1.80%6.91B80.63%2.94B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data